ArticleAnnals of medicine and surgery (2012)2026
Suzetrigine (Journavx): first-in-class NaV1.8 sodium-channel blocker offering non-opioid oral relief for moderate-to-severe acute pain.
Abdullah Imtiaz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.